panipenem-betamipron has been researched along with ro13-9904 in 3 studies
Studies (panipenem-betamipron) | Trials (panipenem-betamipron) | Recent Studies (post-2010) (panipenem-betamipron) | Studies (ro13-9904) | Trials (ro13-9904) | Recent Studies (post-2010) (ro13-9904) |
---|---|---|---|---|---|
68 | 17 | 7 | 6,815 | 798 | 2,755 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
Fukuda, T; Furuta, Y; Minami, S; Mitsuyama, J; Nakata, M; Nomura, N; Takahata, M; Yamada, H | 1 |
Haruta, T; Nonoyama, M; Ouchi, K; Sakata, H; Sato, Y; Sunakawa, K; Yamaguchi, S | 1 |
3 other study(ies) available for panipenem-betamipron and ro13-9904
Article | Year |
---|---|
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
[In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
Topics: 4-Quinolones; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; beta-Alanine; Ceftazidime; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Intravenous; Male; Meropenem; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazines; Rats; Thienamycins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2002 |
[Pediatric bacterial meningitis prognosis and antibiotic treatment].
Topics: Anti-Bacterial Agents; beta-Alanine; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Meningitis, Bacterial; Meropenem; Prognosis; Thienamycins | 2011 |